购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-57 (Compound 93) 为羟基类固醇 17β-脱氢酶 13 (HSD17B13) 的一种抑制剂,其 IC50 值针对雌二醇为 ≤ 0.1 μM。该化合物主要应用于关于肝病、代谢性疾病或心血管疾病研究,如 NAFLD、NASH 或药物性肝损伤 (DILI)。
HSD17B13-IN-57 (Compound 93) 为羟基类固醇 17β-脱氢酶 13 (HSD17B13) 的一种抑制剂,其 IC50 值针对雌二醇为 ≤ 0.1 μM。该化合物主要应用于关于肝病、代谢性疾病或心血管疾病研究,如 NAFLD、NASH 或药物性肝损伤 (DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-57 (Compound 93) acts as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), demonstrating an IC 50 of ≤ 0.1 μM against estradiol. This compound is applicable in the study of various health conditions, including liver, metabolic, and cardiovascular diseases—specifically NAFLD, NASH—and drug-induced liver injury (DILI) [1]. |
分子量 | 554.3 |
分子式 | C24H16Cl2F3N3O5 |
CAS No. | 2770246-86-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容